New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
07:17 EDTBCR, CFN, COV, MASICovidien looking to make acquisitions, NY Times says
Medical device maker Covidien plans to use a portion of its free cash flow for strategic acquisitions in the near-term, the company's CEO said, The New York Times reported yesterday.. Reference Link
News For COV;BCR;MASI;CFN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
07:41 EDTBCRC.R. Bard has a conference call hosted by JPMorgan
Subscribe for More Information
February 19, 2015
11:56 EDTBCRC.R. Bard repoprts CMS approves pass-through payment for Lutonix DCB
Subscribe for More Information
07:12 EDTCFNWharton Health Care Club to hold a conference
Subscribe for More Information
February 17, 2015
16:18 EDTMASIMasimo sees FY15 EPS $1.30, consensus $1.42
Sees FY15 revenue approximately $605M, consensus $624.71M. Masimo is providing 2015 financial guidance. Due to the significant movement in foreign exchange rates over the last four months, and the assumption that those rates will continue throughout 2015, Masimo is, for the first time, providing an estimate of the impact of these foreign exchange rates on its 2015 GAAP financial guidance. Masimo expects fiscal 2015 GAAP total revenues to be approximately $605M. Masimo expects FY15 GAAP total product revenues to be $577M, including an estimated $20M revenue reduction due to unfavorable 2015 foreign exchange rate assumptions impacting product revenues compared to 2014 actual foreign exchange rates. In addition, Masimo expects approximately $28M in FY15 royalty revenues. Masimo also expects FY15 GAAP EPS of approximately $1.30, including an estimated 15c reduction due to the more unfavorable 2015 foreign exchange rate assumptions impacting revenues, cost of sales and operating expenses compared to the 2014 actual foreign exchange rates. Masimo will provide additional financial information during the conference call today. Each of the components of Masimo's guidance set forth above is an estimate only and actual performance could differ.
16:15 EDTMASIMasimo reports Q4 EPS 40c, consensus 37c
Reports Q4 revenue $161.8M, consensus $159.45M.
09:29 EDTCOVMedtronic says FY16 constant currency revenue may be up mid-single digit range
Subscribe for More Information
09:27 EDTCOVMedtronic, Covidien targeting over $850M in cost synergies through FY18
Subscribe for More Information
08:49 EDTCOVMedtronic sees being at high end of Q4 revenue growth range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use